Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Graft Polymer (UK) PLC ( (GB:SVNS) ) has issued an update.
Solvonis Therapeutics PLC, a UK-based company, has announced a change in its major holdings due to an acquisition or disposal of voting rights by Oberon Investments Limited. The notification indicates that Oberon’s voting rights in Solvonis have decreased from 3.209% to 2.176%, impacting the total number of voting rights held in the issuer. This change may influence Solvonis’s shareholder dynamics and potentially affect its decision-making processes.
More about Graft Polymer (UK) PLC
Average Trading Volume: 68,850,913
Technical Sentiment Signal: Hold
Current Market Cap: £17.43M
See more insights into SVNS stock on TipRanks’ Stock Analysis page.